Uterine Artery Doppler and 11-14 / 20-22 Weeks of Gestation Pregnancy
NCT ID: NCT04248660
Last Updated: 2020-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
750 participants
OBSERVATIONAL
2016-01-01
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Postpartum Hemorrhage With Uterine Artery Doppler Measurement
NCT03229304
Study on Doppler Ultrasound Measurement of Changes in Uterine Artery Blood Flow in Normal First Trimester Pregnancies and Its Prediction on Abortion
NCT06043804
Doppler Ultrasonographic Assessment of Fetal Internal Thoracic Artery Indexes
NCT04686240
Uterine Artery Doppler Indices and Uterocervical Angle Measurment in Prediction of Preterm Labor
NCT07336173
Comparison of Brachial Artery Dilatation, Uterine Artery Doppler, Umbilical Artery Doppler and 1st-trimester Visceral Adipose Tissue Measurement in Obese and Normal Pregnant Women
NCT04638504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uterine artery doppler measurements
Uterine artery doppler measurements will be made in the same patients at 11-14 weeks and 20-22 weeks of pregnancy.
Doppler results will be classified according to pregnancy results and primary results will be doppler findings.
uterine artery doppler measurement
The effect of delivery type on changes in uterine blood flow will be investigated.
Doppler results groups will be defined according to the effect of deviations in uterine blood flow on neonatal and perinatal results.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterine artery doppler measurement
The effect of delivery type on changes in uterine blood flow will be investigated.
Doppler results groups will be defined according to the effect of deviations in uterine blood flow on neonatal and perinatal results.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single spontaneous pregnancy
* Having a first pregnancy (primigravid nullipar) or having given birth once (primipar) (first birth by vaginal route or cesarean)
* Result of previous pregnancy with live birth (term delivery without obstetric complication)
* No intrauterine growth restriction in the first pregnancy
* Women who gave birth by cesarean section were not placed due to caesarean indication due to placental location-invasion anomaly, maternal chronic disease (hypertension, diabetes, coronary artery disease, etc.), placental detachment.
Exclusion Criteria
* Pregnancies with assisted reproductive techniques
* Placental anomaly in previous pregnancy
* Maternal chronic hypertension, preeclampsia, history of diabetes
* Pregnant women who smoke
* The presence of fetal chromosomal or structural anomaly
* two or more cesarean sections
* Having undergone non-cesarean surgery (myomectomy, septum or polyp resection ... etc)
* Presence of uterine structural anomaly
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Kadirogulları
principal investigator, Pınar kadirogullari, M.D, Department of Obstetrics and Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATADEK-2020/00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.